Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA ...

Store the inhaler with the mouthpiece down ... or 5-lipoxygenase inhibitors at baseline. Flovent HFA at dosages of 220 and 440 mcg twice daily was evaluated over a 26-week treatment period ...

As of January 1, drug manufacturer GSK has discontinued its Flovent asthma inhaler, and is producing authorized generics in ...

Flovent HFA, GSK’s brand name for its discontinued inhaler, hasn’t been available since December 2023 when, in response to new federal price limits, the company introduced an essentially ...